Galit Alter

49.7k total citations · 7 hit papers
310 papers, 16.6k citations indexed

About

Galit Alter is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Galit Alter has authored 310 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Immunology, 122 papers in Virology and 114 papers in Infectious Diseases. Recurrent topics in Galit Alter's work include HIV Research and Treatment (122 papers), Immune Cell Function and Interaction (121 papers) and Monoclonal and Polyclonal Antibodies Research (88 papers). Galit Alter is often cited by papers focused on HIV Research and Treatment (122 papers), Immune Cell Function and Interaction (121 papers) and Monoclonal and Polyclonal Antibodies Research (88 papers). Galit Alter collaborates with scholars based in United States, Germany and United Kingdom. Galit Alter's co-authors include Marcus Altfeld, Jessica Malenfant, Hendrik Streeck, Todd J. Suscovich, Margaret E. Ackerman, Sarah M. Fortune, Mary Carrington, Madeleine F. Jennewein, Angela Meier and Lenette L. Lu and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Galit Alter

307 papers receiving 16.5k citations

Hit Papers

CD107a as a functional marker for the identification of n... 2004 2026 2011 2018 2004 2017 2022 2022 2022 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD107a as a functional marker for the identification of natural killer cell activity
    2004 1.1k citations Galit Alter, Marcus Altfeld et al. profile →
  2. Beyond binding: antibody effector functions in infectious diseases
    2017 506 citations Todd J. Suscovich, Sarah M. Fortune et al. profile →
  3. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae
    2022 299 citations Zoe Swank, Yasmeen Senussi et al. Clinical Infectious Diseases profile →
  4. A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma
    2022 196 citations Galit Alter, Jonathan Z. Li et al. profile →
  5. Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
    2022 163 citations Galit Alter et al. profile →
  6. The multifaceted roles of breast milk antibodies
    2021 148 citations Caroline Atyeo, Galit Alter profile →
  7. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
    2023 98 citations Galit Alter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galit Alter United States 68 9.6k 5.3k 5.1k 3.1k 3.0k 310 16.6k
Stephen J. Kent Australia 61 6.7k 0.7× 6.1k 1.1× 4.1k 0.8× 3.0k 1.0× 3.6k 1.2× 379 16.2k
Giuseppe Pantaleo Switzerland 71 11.2k 1.2× 6.5k 1.2× 10.6k 2.1× 2.4k 0.8× 4.9k 1.6× 288 19.9k
Rafick‐Pierre Sékaly United States 70 12.1k 1.3× 4.6k 0.9× 8.8k 1.7× 3.4k 1.1× 3.5k 1.2× 310 19.1k
Louis J. Picker United States 77 16.9k 1.8× 4.0k 0.8× 8.0k 1.6× 4.7k 1.5× 6.5k 2.2× 199 29.2k
Christian Brander United States 63 7.7k 0.8× 3.4k 0.6× 7.6k 1.5× 3.2k 1.0× 2.9k 1.0× 242 13.5k
M. Juliana McElrath United States 63 7.5k 0.8× 4.4k 0.8× 8.2k 1.6× 4.4k 1.4× 3.4k 1.1× 261 15.1k
Andrew A. Lackner United States 70 6.5k 0.7× 6.1k 1.1× 8.7k 1.7× 2.4k 0.8× 4.6k 1.5× 261 17.3k
Britta Wahrén Sweden 56 4.5k 0.5× 3.3k 0.6× 4.4k 0.9× 3.1k 1.0× 5.4k 1.8× 491 13.7k
Dan H. Barouch United States 71 9.6k 1.0× 6.1k 1.1× 6.2k 1.2× 5.8k 1.9× 4.1k 1.4× 321 19.6k
Peter C. L. Beverley United Kingdom 71 11.8k 1.2× 2.5k 0.5× 3.6k 0.7× 3.8k 1.2× 3.3k 1.1× 297 19.0k

Countries citing papers authored by Galit Alter

Since Specialization
Citations

This map shows the geographic impact of Galit Alter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Alter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Alter more than expected).

Fields of papers citing papers by Galit Alter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galit Alter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Alter. The network helps show where Galit Alter may publish in the future.

Co-authorship network of co-authors of Galit Alter

This figure shows the co-authorship network connecting the top 25 collaborators of Galit Alter. A scholar is included among the top collaborators of Galit Alter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galit Alter. Galit Alter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spatola, Marianna, Edward B. Irvine, Deniz Cizmeci, et al.. (2024). Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection. Brain. 147(9). 3247–3260. 7 indexed citations
2.
Loos, Carolin, Margherita Coccia, Arnaud M. Didierlaurent, et al.. (2023). Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. npj Vaccines. 8(1). 34–34. 14 indexed citations
3.
Burns, Madeleine D., Yannic C. Bartsch, Jameson P. Davis, et al.. (2023). Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children. Pediatric Research. 94(4). 1327–1334. 1 indexed citations
4.
Boudreau, Carolyn M., John S. Burke, Kiel Shuey, et al.. (2022). Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial. Cell Reports. 38(6). 110337–110337. 3 indexed citations
5.
Kapłonek, Paulina, Deniz Cizmeci, Stephanie Fischinger, et al.. (2022). mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions. Science Translational Medicine. 14(645). eabm2311–eabm2311. 76 indexed citations
6.
Bartsch, Yannic C., et al.. (2022). Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPSTM) SARS-CoV-2 Vaccine. Vaccines. 10(7). 1069–1069. 2 indexed citations
7.
Kevin, C., Jaime E. Hale, Yonatan H. Grad, et al.. (2022). Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens. Clinical Infectious Diseases. 75(1). e105–e113. 3 indexed citations
8.
Swank, Zoe, Yasmeen Senussi, Zachary Manickas-Hill, et al.. (2022). Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical Infectious Diseases. 76(3). e487–e490. 299 indexed citations breakdown →
9.
Nilles, Eric J., Elizabeth W. Karlson, Maia Norman, et al.. (2021). Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. The Journal of Applied Laboratory Medicine. 6(6). 1561–1570. 8 indexed citations
10.
Tokuyama, Maria, Bronwyn M. Gunn, Arvind Venkataraman, et al.. (2021). Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. The Journal of Experimental Medicine. 218(7). 37 indexed citations
11.
Jin, Celina, Jennifer Hill, Bronwyn M. Gunn, et al.. (2020). Vi-specific serological correlates of protection for typhoid fever. The Journal of Experimental Medicine. 218(2). 45 indexed citations
12.
Angeletti, Davide, Ivan Košík, Jefferson Santos, et al.. (2019). Outflanking immunodominance to target subdominant broadly neutralizing epitopes. Proceedings of the National Academy of Sciences. 116(27). 13474–13479. 55 indexed citations
13.
Fox, Julie M., Vicky Roy, Bronwyn M. Gunn, et al.. (2019). Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science Immunology. 4(32). 58 indexed citations
14.
Lofano, Giuseppe, Matthew J. Gorman, Ashraf S. Yousif, et al.. (2018). Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Science Immunology. 3(26). 66 indexed citations
15.
Chung, Amy W., Matthew K. Schoen, Hannah R. Robinson, et al.. (2014). Polyfunctional Non-neutralizing Fc-antibody Responses in Acute HIV Infection Predict Spontaneous Viral Control. AIDS Research and Human Retroviruses. 30(S1). A89–A89. 1 indexed citations
16.
Euler, Zelda & Galit Alter. (2014). Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication. AIDS Research and Human Retroviruses. 31(1). 13–24. 41 indexed citations
17.
Malaspina, Angela, et al.. (2013). Conference Report: “Functional Glycomics in HIV Type 1 Vaccine Design” Workshop Report, Bethesda, Maryland, April 30–May 1, 2012. AIDS Research and Human Retroviruses. 29(11). 1407–1417. 2 indexed citations
18.
Wong, Ambrose H., Katie Williams, Sharon Reddy, et al.. (2010). Alterations in Natural Killer Cell Receptor Profiles During HIV Type 1 Disease Progression Among Chronically Infected South African Adults. AIDS Research and Human Retroviruses. 26(4). 459–469. 23 indexed citations
19.
Minkis, Kira, Daniel G. Kavanagh, Galit Alter, et al.. (2008). Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 by IL-12p70 mRNA–Transfected Dendritic Cells. Cancer Research. 68(22). 9441–9450. 46 indexed citations
20.
Meier, Angela, Galit Alter, Nicole Frahm, et al.. (2007). MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands. Journal of Virology. 81(15). 8180–8191. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Kent Breakdown of academic impact, for papers by Giuseppe Pantaleo Breakdown of academic impact, for papers by Rafick‐Pierre Sékaly Breakdown of academic impact, for papers by Louis J. Picker Breakdown of academic impact, for papers by Christian Brander Breakdown of academic impact, for papers by M. Juliana McElrath Breakdown of academic impact, for papers by Andrew A. Lackner Breakdown of academic impact, for papers by Britta Wahrén Breakdown of academic impact, for papers by Dan H. Barouch Breakdown of academic impact, for papers by Peter C. L. Beverley
Rankless by CCL
2026